NeoHack Secures Patent for 'Compositions and Methods of Achieving Pain Relief"
NeoHack Life Sciences Principals
Chief Executive Officer
Ron Butler, MBA
Scottsdale, AZ
Previously Chairman and CEO, EVP, and CMO of NYSE, AMEX and NASDQ traded companies
in pet products industry, home centers, hardware distribution, and furniture manufacturing
Former EVP PetSMART
Board Committees: Corporate Governace, Audit, Compensation
20 year member Wake Forest Business School Board
Pro Humanitate Society
Pepperdine University Board, former member
contact: rb@neohacksciences.com
Chief Science Officer
Dr. Dale Brown, PhD
Wharton, TX
Authored and Co-Authored over 40 PATENTS
Homeostasis Researcher
Inflammation Researcher using components of the Inflammasomes
Recipient, American Cyanamid's Scientific Achievement Award
Published Academic Author
Chemical Synthesis and Formulation expert
University of North Texas (Formerly North Texas State University)
contact: db@neohacksciences.com
The NeoHack Story
The accidental discovery of penicillin by Sir Alexander Fleming is legend, but most discoveries are not accidental and often result from corroborating observations and following scientific methods.
Such is the case with NeoHack Life Sciences, LLC. Our origins are based in an FDA licensed environment commanding rigid Good Manufacturing Practices to make ingredients and formulations for some of the most recognizable brands in the worldwide oral care markets.
Many of those formulations are availble through drug stores, mass merchant retailers and internet merchant sites today.
Out of our 30-year body of oral health work, a pleasant formulation emerged -- a dry mouth remedy owned by NeoHack -- branded as Hydralief. Its science was sound, and it was no accident that the healing effects for xerostomia (dry mouth) led to other discoveries. It was found to be effective for healing in mucosal tissues—and then in stopping herpes simplex (cold sores) -- and for other dermal issues via topical application.
As good scientists do, we “followed the science” from our dry mouth invention and discovered that a key ingredient derived from an African flower was dubbed “the toothache plant”. Hence the journey from dry mouth to pain relief began.
NeoHack is excited about The NEXT GENERATION of malady treatments and believes that its focus on restoring the body’s homeostasis will change the field of pain relief for years to come.
Keep following our website, www.NeoHackSciences.com, for developing research on Alzheimer’s, inflammation, inflammasomes, migraines, and other non-homeostasis-related ailments.
